Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Aikawa, Tokyo
Fumiko Aikawa, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20100166728 | Novel Highly Functional Enzyme Having Modified Substrate-Specificity - The present invention provides, as an enzyme which can be used for enzyme replacement therapy for Fabry disease, a protein having α-galactosidase activity, which shows no allergic adverse side effect, shows a high stability in blood, and can be easily incorporated into a cell of an affected organ. The protein of the present invention is a protein which has acquired α-galactosidase activity by changing the structure of the active site of wild-type human α-N-acetylgalactosaminidase. | 07-01-2010 |
| 20100291059 | PHARMACEUTICAL COMPOSITION FOR ENZYME REPLACEMENT THERAPY - The present invention provides a pharmaceutical composition comprising a protein having α-galactosidase activity for treating Fabry disease, which causes no allergic side effect, which is highly stable in blood (plasma) and which can readily be taken up by a cell of an affected organ. The pharmaceutical composition for treating Fabry disease of the invention comprises, for example, a protein which acquires an α-galactosidase activity through alteration of the structure of the active site of wild-type human α-N-acetylgalactosaminidase. | 11-18-2010 |
| 20110171198 | HIGHLY FUNCTIONAL ENZYME HAVING ALPHA-GALACTOSIDASE ACTIVITY - The present invention provides, as an enzyme which can be used for enzyme replacement therapy for Fabry disease, a protein having α-galactosidase activity, which shows no allergic adverse side effect, shows a high stability in blood, and can be easily incorporated into a cell of an affected organ. The protein of the present invention is a protein which has acquired α-galactosidase activity by changing the structure of the active site of wild-type human α-N-acetylgalactosaminidase. | 07-14-2011 |
Hideto Aikawa, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20080309465 | Radio Ic Tag Communication System - A communication system includes a wireless IC tag and a reader/writer that performs reading and writing on the wireless IC tag via wireless communication. The reader/writer includes an error control encoder and an error control decoder. On writing data into the wireless IC tag, the reader/writer encodes the data by the error control encoder and writes real data separately from error-control-decodable data. On reading out data from the wireless IC tag, the reader/writer selects whether to read out only the real data or to read out data including error-control-decodable information to decode the data by the error control decoder based on error control information indicating whether to perform error control or not. | 12-18-2008 |
Kohsuke Aikawa, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20090312574 | Method for Producing Optically Active Fluorine-Containing Carbonyl-ene Product - An optically active, fluorine-containing carbonyl-ene product is produced by reacting a fluorine-containing α-ketoester with an alkene in the presence of a transition metal complex having an optically active ligand. There are Mode 1 of conducting this reaction in the absence of reaction solvent, Mode 2 of conducting this reaction in a solvent that is low in relative dielectric constant, and Mode 3 of conducting this reaction in a halogenated hydrocarbon-series solvent. In each of these three modes, it is possible to produce the optically active, fluorine-containing carbonyl-ene product with low cost. | 12-17-2009 |
| 20110306781 | Method for Producing Optically Active Fluorinated Oxetane - Disclosed is a method of producing an optically active fluorinated oxetane, which can be an important pharmaceutical or agricultural intermediate, by reaction of a fluorinated α-keto ester with an acyl alkenyl ether in the presence of a transition metal complex with an optically active ligand. This method utilizes a catalytic asymmetric synthesis process and does not require a stoichiometric amount of chiral source. It is thus possible to dramatically reduce the amount of use of the asymmetric catalyst especially when the reaction is performed at a high concentration of substrate (with the use of a small amount of reaction solvent) or in the absence of a reaction solvent (under neat conditions). Further, the target optically active fluorinated oxetane can be obtained with high yield and with very high optical purity. The product contains almost no difficult-to-separate impurity and shows high chemical purity. | 12-15-2011 |
Mari Aikawa, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20120009112 | METHOD FOR PREPARING HIGH-PURITY ELEMENTAL PHOSPHORUS AND METHOD FOR PREPARING HIGH-PURITY PHOSPHORIC ACID - Provided is a method for preparing high-purity elemental phosphorus capable of simultaneously reducing both arsenic and antimony from crude white phosphorus containing a great amount of arsenic and antimony as impurities. | 01-12-2012 |
Masami Aikawa, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20100188204 | DISPLAY DEVICE FOR VEHICLE - A display device for vehicles has a screen | 07-29-2010 |
Naoki Aikawa, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20090016987 | Pharmaceutical composition and therapeutic method - The object of the present invention is, based on the finding of a novel effect of IL-18, to provide pharmaceutical compositions containing IL-18 and therapeutic methods, for preventing, improving, or treating inflammatory diseases such as systemic inflammatory response syndrome (SIRS). Inflammatory diseases, such as SIRS, can be prevented, improved, or treated by administering the pharmaceutical compositions according to the present invention containing IL-18 in an amount which does not bring the decreased interleukin 18 level in either plasma or liver to a higher level than normal. | 01-15-2009 |
Naoyuki Aikawa, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20090125575 | NOISE CANCELING DEVICE, WEIGHING DEVICE, METHOD OF CANCELING A NOISE, AND METHOD OF DESIGNING A DIGITAL FILTER - It is an object of the present invention to provide techniques which allow for easier change in filter characteristics of a digital filter. Then, in order to attain this object, in a weighing device according to the present invention, a filter coefficient calculator ( | 05-14-2009 |
Seiichi Aikawa, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20100166728 | Novel Highly Functional Enzyme Having Modified Substrate-Specificity - The present invention provides, as an enzyme which can be used for enzyme replacement therapy for Fabry disease, a protein having α-galactosidase activity, which shows no allergic adverse side effect, shows a high stability in blood, and can be easily incorporated into a cell of an affected organ. The protein of the present invention is a protein which has acquired α-galactosidase activity by changing the structure of the active site of wild-type human α-N-acetylgalactosaminidase. | 07-01-2010 |
| 20100291059 | PHARMACEUTICAL COMPOSITION FOR ENZYME REPLACEMENT THERAPY - The present invention provides a pharmaceutical composition comprising a protein having α-galactosidase activity for treating Fabry disease, which causes no allergic side effect, which is highly stable in blood (plasma) and which can readily be taken up by a cell of an affected organ. The pharmaceutical composition for treating Fabry disease of the invention comprises, for example, a protein which acquires an α-galactosidase activity through alteration of the structure of the active site of wild-type human α-N-acetylgalactosaminidase. | 11-18-2010 |
| 20110171198 | HIGHLY FUNCTIONAL ENZYME HAVING ALPHA-GALACTOSIDASE ACTIVITY - The present invention provides, as an enzyme which can be used for enzyme replacement therapy for Fabry disease, a protein having α-galactosidase activity, which shows no allergic adverse side effect, shows a high stability in blood, and can be easily incorporated into a cell of an affected organ. The protein of the present invention is a protein which has acquired α-galactosidase activity by changing the structure of the active site of wild-type human α-N-acetylgalactosaminidase. | 07-14-2011 |
Shinya Aikawa, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20120063013 | FOCUS ADJUSTING EQUIPMENT - According to one embodiment, focus adjusting equipment is provided. The focus adjusting equipment is provided with a rotational driving unit, a focus lens unit, a cam gear and a cam. The rotational driving unit generates a rotational force. The focus lens unit is provided with a focus lens and a motion converting unit. The focus lens is movable in an optical axis direction. The motion converting unit converts a rotational motion into a linear motion of the focus lens. The cam gear rotates in association with the rotation of the rotational driving unit. The cam rotates with the cam gear integrally. The cam contacts with an actuating part of the motion converting unit so as to transmit the rotational motion of the cam gear to the motion converting unit. | 03-15-2012 |
Shozo Aikawa, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20110154961 | TORQUE WRENCH - To make improvements in torque wrenches with a torque limiter that uses a cam mechanism and to provide a torque wrench that realizes more stable operation and is capable of highly precise tightening. In a torque wrench with a torque limiter that uses a cam mechanism, a solid columnar roller member | 06-30-2011 |
| 20120011971 | TORQUE WRENCH - A torque wrench equipped with a cam-type torque detection mechanism is provided which is capable of detecting a torque with high accuracy, providing a non-unusual-feeling of handle operation after torque has been detected, and enabling tightening of fastened members such as bolts with safety. In a torque wrench equipped with the cam-type torque detection mechanism, a cam portion | 01-19-2012 |
Susumu Aikawa, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20120060203 | LOGICAL UNIT NUMBER MANAGEMENT DEVICE, LOGICAL UNIT NUMBER MANAGEMENT METHOD, AND PROGRAM THEREFOR - A logical unit number management device includes: an access processing unit that performs information processing with access objects by using logical unit numbers for identifying logical identification information; a logical unit number management table storage unit that stores a logical unit number management table storing a corresponding relationship between the logical identification information and the logical unit numbers; a logical unit number management table changing unit that changes the corresponding relationship based on an external change request; a change completion reporting unit that reports change completion to the access processing unit when the logical unit number management table has been changed in accordance with the change request; and an access control unit that controls an access to the access object indicated by the logical identification information corresponding to one of the logical unit numbers after a report of the change completion. | 03-08-2012 |
Tomonori Aikawa, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20080313343 | COMMUNICATION APPARATUS, APPLICATION COMMUNICATION EXECUTING METHOD, AND COMPUTER PROGRAM PRODUCT - A software communication unit executes a plurality of application communications executed in parallel in a network according to a TCP/IP control by a software. A hardware communication unit executes the application communications according to a TCP/IP control by a TCP/IP offload engine (TOE). A communication allocating unit executes an allocation processing for allocating a hardware communication by the hardware communication unit and a software communication by the software communication unit based on reference information on each of the application communications, for application communications that are simultaneously executed. | 12-18-2008 |
| 20110022631 | IMAGE FORMING APPARATUS, DISPLAY CONTROL METHOD, AND RECORDING MEDIUM - An image forming apparatus is disclosed including a search request transmission unit transmitting a search request to a predetermined resource in a network, a response receiving unit receiving response information in response to the search request, and storing the received response information in a storage unit, a list screen display control unit displaying a list screen including a display element corresponding to each response information stored in the storage unit within a first predetermined time period. When the list screen is changed to another screen and then changed back again to the list screen, the list screen display control unit displays the list screen including the display element corresponding to response information stored in the storage unit after the first predetermined time period has passed. | 01-27-2011 |
Yuki Aikawa, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20090219455 | Liquid Crystal Display Apparatus - A liquid crystal display apparatus which includes an optical compensation layer in addition to a liquid crystal panel and which is capable of preventing degradation of the optical compensation layer, thereby providing high long-term reliability in display characteristics, is provided. The liquid crystal display apparatus includes a liquid crystal panel | 09-03-2009 |